Found 291 matching trials
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
PHASE1Multiple myeloma (MM) is a malignancy characterized by uncontrolled prolife...
Location
Mount Sinai Health System
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
PHASE4Platform adaptive embedded trial for acute respiratory distress syndrome (P...
Location
Peking Union Medical College Hospital
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma
PHASE2The purpose of this study was to determine clinical efficacy and safety of ...
Location
Multiple Locations
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
PHASE2This research study is investigating the safety and effectiveness of using ...
Location
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
PHASE2Note: The study data was transferred to zr pharma\& following the divestmen...
Location
Novartis Investigative Site
Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults
PHASE2Phase 2, randomized, open-label study to evaluate the safety and efficacy o...
Location
Hospital General de México "Dr. Eduardo Liceaga"
India Dexamethasone and Betamethasone
PHASE1An open label, randomized, two-period, crossover, study to compare the phar...
Location
Syngene International Limited, Tower I
Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors
PHASE1Primary Objective:
* To evaluate tolerability and safety of SAR408701 when...
Location
Investigational Site Number : 3920002
Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM
PHASE1The purpose of this study is to evaluate the safety and efficacy of mitoxan...
Location
Beijing Chaoyang Hospital, Capital Medical University
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
PHASE3Researchers are looking for new ways to treat types of breast cancer that a...
Location
Banner MD Anderson Cancer Center ( Site 0066)